Where CB1 receptors are located in the brain determines how cannabinoids affect memory and appetite

CB1 receptors on different cell types (glutamate neurons, GABA neurons, astrocytes, mitochondria) produce distinct and sometimes opposite effects on memory and feeding behavior.

Busquets-Garcia, Arnau et al.·BioEssays : news and reviews in molecular·2015·Moderate EvidenceReview
RTHC-00928ReviewModerate Evidence2015RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

This review examined how the location of CB1 receptors across different brain cell types and subcellular compartments determines the specific behavioral effects of cannabinoids. CB1 receptors are widely distributed across the brain on glutamatergic neurons, GABAergic neurons, astrocytes, and even on mitochondria within cells.

The same receptor produces different molecular and cellular effects depending on which cell type expresses it. For example, CB1 receptors on glutamatergic neurons and GABAergic neurons mediate different aspects of memory and feeding. CB1 receptors on astrocytes contribute to memory through distinct mechanisms. Even CB1 receptors on mitochondria within cells influence energy metabolism differently.

The authors argued that understanding these site-specific actions is essential for developing targeted cannabinoid-based medicines that produce desired effects without unwanted ones.

Key Numbers

CB1 receptors identified on at least 4 cell types (glutamatergic neurons, GABAergic neurons, astrocytes, mitochondria). Effects analyzed in two behavioral domains: memory and feeding.

How They Did This

Narrative review synthesizing research on cell-type-specific and subcellular-compartment-specific functions of CB1 receptors, with a focus on memory and feeding behavior.

Why This Research Matters

The location-dependent effects of CB1 receptors explain why cannabis produces such a wide range of effects simultaneously. This knowledge could enable development of cannabinoid medicines that target specific cell types to treat conditions like appetite disorders or memory problems without broad side effects.

The Bigger Picture

Cannabis affects so many different functions because its receptors are found on virtually every type of brain cell. The next generation of cannabinoid medicines may need to target specific cell populations rather than activating all CB1 receptors indiscriminately.

What This Study Doesn't Tell Us

Much of the evidence comes from genetic knockout mice, which completely remove receptors from cell types rather than modulating them. Human confirmation of cell-type-specific effects is limited.

Questions This Raises

  • ?Can drugs be designed to target CB1 receptors on specific cell types?
  • ?How do the relative proportions of CB1 receptors on different cells change with chronic cannabis use?

Trust & Context

Key Stat:
Same receptor, different cell types, different behavioral effects
Evidence Grade:
Narrative review of predominantly preclinical research on cell-type-specific CB1 receptor functions.
Study Age:
Published in 2015. Cell-type-specific cannabinoid research has continued to advance.
Original Title:
Dissecting the cannabinergic control of behavior: The where matters.
Published In:
BioEssays : news and reviews in molecular, cellular and developmental biology, 37(11), 1215-25 (2015)
Database ID:
RTHC-00928

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Why does cannabis affect both memory and appetite?

CB1 receptors are found on many different brain cell types. The same receptor on glutamate neurons, GABA neurons, and support cells produces different effects, which is why cannabis simultaneously affects memory, appetite, and many other functions.

Could targeted cannabinoid drugs avoid side effects?

In theory, yes. If drugs could activate CB1 receptors on specific cell types rather than all cells, they might produce therapeutic effects without the broad range of side effects seen with whole cannabis.

Read More on RethinkTHC

Cite This Study

RTHC-00928·https://rethinkthc.com/research/RTHC-00928

APA

Busquets-Garcia, Arnau; Desprez, Tifany; Metna-Laurent, Mathilde; Bellocchio, Luigi; Marsicano, Giovanni; Soria-Gomez, Edgar. (2015). Dissecting the cannabinergic control of behavior: The where matters.. BioEssays : news and reviews in molecular, cellular and developmental biology, 37(11), 1215-25. https://doi.org/10.1002/bies.201500046

MLA

Busquets-Garcia, Arnau, et al. "Dissecting the cannabinergic control of behavior: The where matters.." BioEssays : news and reviews in molecular, 2015. https://doi.org/10.1002/bies.201500046

RethinkTHC

RethinkTHC Research Database. "Dissecting the cannabinergic control of behavior: The where ..." RTHC-00928. Retrieved from https://rethinkthc.com/research/busquets-garcia-2015-dissecting-the-cannabinergic-control

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.